Dr. Jonathan N. Swerdloff, MD
Medical Oncology (Medical Oncology Physician)
308 E Hawaii Ave
Nampa, ID 83686
Who else practices at this address →
Canyon County is a federal mental health shortage area. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of California, Geffen School of Medicine (1997)
- Years since graduation
- 29
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 344
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1997Medical school: University of California, Geffen School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Medical Oncology Physician primary
ID license M8879 -
Hematology & Oncology Physician
ID license M8879
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- St Luke's Regional Medical Center Boise, ID
- St Luke's Nampa Medical Center Nampa, ID
- Grande Ronde Hospital La Grande, OR
Medical groups
- St Lukes Clinic-Treasure Valley LLC (1,173 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 344
- Services billed
- 984
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 463 | 209 |
| Established patient office or other outpatient visit, 20-29 minutes | 174 | 142 |
| Established patient office or other outpatient visit, 40-54 minutes | 141 | 67 |
| New patient office or other outpatient visit, 45-59 minutes | 55 | 55 |
| New patient office or other outpatient visit, 60-74 minutes | 13 | 13 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Anastrozole Other prescribers in Nampa, ID | 145 |
| Ondansetron Odt (ondansetron) Other prescribers in Nampa, ID | 132 |
| Acyclovir Other prescribers in Nampa, ID | 120 |
| Tamoxifen Citrate Other prescribers in Nampa, ID | 115 |
| Prochlorperazine Maleate Other prescribers in Nampa, ID | 108 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Nampa, ID | 87 |
| Prednisone Other prescribers in Nampa, ID | 66 |
| Revlimid (lenalidomide) | 59 |
| Letrozole Other prescribers in Nampa, ID | 56 |
| Eliquis (apixaban) Other prescribers in Nampa, ID | 55 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $4,450 in research payments for these studies, mostly to the institutions running them.
- HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy
Daiichi Sankyo Inc. · Active, not recruiting · NCT05338970
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.